EP4483956
TRORILUZOLE TIL NOTKUNAR VIÐ MEÐFERÐ SPINOCEREBELLAR ATAXÍU 3 (SCA3)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.11.2018EP published:
31.12.2025EP application number:
24199849.1
EP translation filed:
18.3.2026Grant published:
8.4.2026EPO information:
European Patent Register
Max expiry date:
10.11.2038Expiry date:
10.11.2026
Title in English:
TRORILUZOLE FOR USE IN THE TREATMENT OF SPINOCEREBELLAR ATAXIA 3 (SCA3)Language of the patent:
English
Timeline
Today
11.11.2018EP application
31.12.2025EP Publication
18.3.2026Translation submitted
8.4.2026Registration published
10.11.2026Expires
Owner
Name:
Biohaven Therapeutics Ltd.Address:
215 Church Street, New Haven, CT 06510, US
Inventor
Name:
CORIC, VladimirAddress:
New Haven, 06510, US
Name:
BERMAN, RobertAddress:
New Haven, 06510, US
Name:
BEINER, MelissaAddress:
New Haven, 06510, US
Name:
L'ITALIEN, GilbertAddress:
New Haven, 06510, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201762584856 PDate:
12.11.2017Country:
US
Number:
201862717948 PDate:
13.8.2018Country:
US
Classification
Categories:
A61K 31/428, A61K 31/427, A61K 31/4985, A61P 35/00, C07D 277/82, C07D 417/12, A61K 9/48, A61K 9/20, A61P 25/14, A61K 45/06